Prestige Consumer Healthcare (NYSE:PBH) Earns Buy Rating from Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of Prestige Consumer Healthcare (NYSE:PBH) in a research report report published on Tuesday, Benzinga reports. They currently have a $80.00 target price on the stock.

PBH has been the topic of a number of other research reports. StockNews.com lowered shares of Prestige Consumer Healthcare from a strong-buy rating to a buy rating in a report on Tuesday. TheStreet upgraded Prestige Consumer Healthcare from a c+ rating to a b- rating in a report on Monday, February 12th. Finally, DA Davidson restated a neutral rating and set a $65.00 price objective on shares of Prestige Consumer Healthcare in a research report on Thursday, May 16th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of Moderate Buy and an average price target of $91.25.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $63.83 on Tuesday. Prestige Consumer Healthcare has a twelve month low of $55.96 and a twelve month high of $75.31. The company has a current ratio of 3.20, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average of $69.90 and a two-hundred day moving average of $65.37. The company has a market capitalization of $3.19 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 1.84 and a beta of 0.53.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.12). The business had revenue of $277.00 million for the quarter, compared to analyst estimates of $287.42 million. Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.07 earnings per share. As a group, analysts expect that Prestige Consumer Healthcare will post 4.41 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Prestige Consumer Healthcare by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company’s stock worth $352,391,000 after acquiring an additional 63,375 shares during the last quarter. Ariel Investments LLC increased its stake in shares of Prestige Consumer Healthcare by 173.8% in the third quarter. Ariel Investments LLC now owns 2,534,786 shares of the company’s stock worth $144,964,000 after purchasing an additional 1,609,044 shares during the period. Massachusetts Financial Services Co. MA lifted its position in shares of Prestige Consumer Healthcare by 0.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,101,504 shares of the company’s stock worth $62,995,000 after purchasing an additional 8,661 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Prestige Consumer Healthcare by 0.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,047,352 shares of the company’s stock valued at $75,996,000 after buying an additional 4,278 shares during the last quarter. Finally, Congress Asset Management Co. MA lifted its holdings in shares of Prestige Consumer Healthcare by 12.5% during the first quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company’s stock worth $55,437,000 after buying an additional 84,757 shares during the last quarter. Institutional investors own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.